CD44 and breast carcinoma: In addition, we observed that LLL12 inhibited cell viability (Figure 5D) and tumorsphere forming capacity (Figure 5E) in the ALDH+/CD44+/CD24+ subpopulation of MDA-MB-231 and SUM159 breast cancer cells.